Phase I, multicenter, dose‐escalation study of avadomide in adult Japanese patients with advanced malignancies

Non‐Hodgkin lymphoma (NHL) treated with chemoimmunotherapy has limited efficacy in some patients, resulting in relapsed or refractory disease. Avadomide (CC‐122) is a novel cereblon‐binding agent that exhibits antilymphoma and immune‐modulation activities with a biological profile distinct from simi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatake, Kiyohiko, Chou, Takaaki, Doi, Toshihiko, Terui, Yasuhito, Kato, Harumi, Hirose, Takayuki, Seo, Sachiko, Pourdehnad, Michael, Ogaki, Yumi, Fujimoto, Hiroshi, Hagner, Patrick R., Yamamoto, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780008/
https://www.ncbi.nlm.nih.gov/pubmed/33075165
http://dx.doi.org/10.1111/cas.14704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780008/
https://www.ncbi.nlm.nih.gov/pubmed/33075165
http://dx.doi.org/10.1111/cas.14704

Ejemplares similares